Form D · Biotechnology
Soltego, Inc.
Newton, MA · CIK 0001761032
Offering snapshot reported Apr 25, 2019 · SEC filing
- Reported sold
- $6.74M Offering amount: $6.74M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 22, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2019 | Initial | $6,741,846 | No comparison | 4 | SEC filing |
| Dec 18, 2018 | Initial | $600,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-338135
Principal and interest of $641,847 converted from outstanding Issuer Promissory Notes.
Preferred Stock can convert to underlying shares of Common Stock
Source: Form D, filed Apr 25, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Craig Drill | Director |
| Irina Erenburg | Director, Executive |
| David Fisher | Director |
| Nathanael S Gray | Director |
| Philippe Schaison | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
510 Ward Street
Newton, MA, 02459
Newton, MA, 02459